METTL3 was found to upregulate glycolysis in CRC by stabilizing HK2 and SLC2A1 in an m6A-IGF2BP2/3-dependent manner, leading to cancer progression [41]. This evidence concerns the gene IGF2BP2 and colorectal carcinoma.